Apac Pharmaceutical

Lupin Pharmaceuticals specializes in the design and development of a variety of generic medicines. Operational since 2003, the company s facilities are approved by the Food and Drug Administration. It develops and markets a range of drugs for children under the Suprax brand. The company maintains more than 10 manufacturing facilities in the United States. Lupin Pharmaceuticals is a wholly owned subsidiary of Lupin Limited, which is one of the leading pharmaceutical companies in India. With annual revenues of over $690 million, Lupin Limited maintains a research and development center in Pune in India. The company specializes in the development of drugs for the treatment of diabetes.

Incorporated in 1989, Otsuka America Pharmaceutical is a health care company that commercializes its products throughout North America. It offers products under the ABILIFY Tablets1 and PLETAL Tablets2 brands. The company works in collaboration with Bristol-Myers Squibb, which co-develops and co-promotes ABILIFY. Otsuka America Pharmaceutical has also merged with Meretek Diagnostics to form the Meretek Diagnostics Group under the Medical Device Division of OAPI. It focuses on neuroscience, cardiovascular, oncologic and gastrointestinal therapeutic treatments. The company operates Otsuka Maryland Research Institute, which was established as a wholly-owned subsidiary of OAPI to research and develop a variety of health care products. Otsuka America Pharmaceutical is a part of Otsuka Pharmaceutical Group.

Pharmaceutics International, located in Hunt Valley, MD, is a leading pharmaceutical development and manufacturing company. With a team of experienced scientists and state-of-the-art technologies, they offer a wide range of services, including formulation process development, oral and parenteral drug development, aseptic manufacturing, lyophilization cycle development, and clinical trial manufacturing. Their relentless commitment to optimized product development ensures that they can tackle any formulation challenge and accelerate timelines, all while staying on budget. Proudly offering flexible solutions for solubility and bioavailability enhancement, Pharmaceutics International has extensive scientific expertise in improving the dissolution rate of challenging drugs. They utilize various formulation techniques, such as solid dispersions, nanoparticles, and spray-drying, to enhance the solubility and permeability of drugs. Additionally, their expertise in lyophilization cycle development allows them to de-risk the product development process by studying thermal characteristics and scaling up for GMP manufacturing. Pharmaceutics International is dedicated to providing high-quality pharmaceutical solutions to their partners in the pharmaceutical and biotech industries.Generated from the website